Floatz logo

ATENOLOL

Blood Pressure

Ajou University School of MedicineSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Blood Pressure cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
AMLODIPINE
Yuhan Corporation
Phase 4BBB
Dapagliflozin
University of Campinas, Brazil
Phase 4BB
vi-0521
VIVUS LLC
Phase 4BB
LABETALOL
ProMedica Health System
Phase 3BB

View all 44 →

Same molecule, other indications

ATENOLOL is also rated in:

stroke disorderDormant
BBB
Indicative ·
75 / 100
View asset →
myocardial ischemiaDormant
BBB
Indicative ·
75 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →